Search research articles
Contact Us
Filters
Showing results (101-110 of 218) with videos related to
Page
of 22
Sort By:
Tumori
|
October 31, 1993
Immunotherapy with low-dose subcutaneous interleukin-2 plus beta-interferon as a second-line therapy for metastatic colorectal carcinoma
S Barni, P Lissoni, A Ardizzola, et al.
Journal of Biological Regulators and Homeostatic Agents
|
October 1, 1989
Alterations of pineal gland and of T lymphocyte subsets in metastatic cancer patients: preliminary results
P Lissoni, G Tancini, S Barni, et al.
Journal of Pineal Research
|
November 1, 1996
Adjuvant therapy with the pineal hormone melatonin in patients with lymph node relapse due to malignant melanoma
P Lissoni, O Brivio, F Brivio, et al.
In Vivo (Athens, Greece)
|
March 27, 2003
Clinical and biological effects of interleukin-2 with or without a concomitant administration of granulocyte-macrophage colony-stimulating factor in metastatic cancer patients
P Lissoni, S Mengo, R Bucovec, et al.
The International Journal of Biological Markers
|
February 24, 2001
Chemotherapy and angiogenesis in advanced cancer: vascular endothelial growth factor (VEGF) decline as predictor of disease control during taxol therapy in metastatic breast cancer
P Lissoni, E Fugamalli, F Malugani, et al.
Journal of Biological Regulators and Homeostatic Agents
|
April 7, 2004
A psychoncological study of lymphocyte subpopulations in relation to pleasure-related neurobiochemistry and sexual and spiritual profile to Rorschach's test in early or advanced cancer patients
G Messina, P Lissoni, E Bartolacelli, et al.
Journal of Biological Regulators and Homeostatic Agents
|
October 1, 1996
Reactivation of a normal endogenous secretion of interleukin-2 in metastatic cancer patients by a chronic subcutaneous injection of interleukin-2
G Di Felice, L Fumagalli, F Majorca, et al.
Cancer Treatment Reports
|
February 1, 1976
Combination chemotherapy with DTIC (NSC-45388) in advanced malignant melanoma, soft tissue sarcomas, and Hodgkin's disease
G Beretta, G Bonadonna, E Bajetta, et al.
Oncology
|
November 1, 1993
A study of the mechanisms involved in the immunostimulatory action of the pineal hormone in cancer patients
P Lissoni, S Barni, G Tancini, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1990
The biological significance of soluble interleukin-2 receptors in solid tumors
P Lissoni, S Barni, F Rovelli, et al.
Page
of 22
Search research articles
Search
Showing results (101-110 of 218) with videos related to
Sort By:
Page
of 22
Tumori
|
October 31, 1993
Immunotherapy with low-dose subcutaneous interleukin-2 plus beta-interferon as a second-line therapy for metastatic colorectal carcinoma
S Barni, P Lissoni, A Ardizzola, et al.
Journal of Biological Regulators and Homeostatic Agents
|
October 1, 1989
Alterations of pineal gland and of T lymphocyte subsets in metastatic cancer patients: preliminary results
P Lissoni, G Tancini, S Barni, et al.
Journal of Pineal Research
|
November 1, 1996
Adjuvant therapy with the pineal hormone melatonin in patients with lymph node relapse due to malignant melanoma
P Lissoni, O Brivio, F Brivio, et al.
In Vivo (Athens, Greece)
|
March 27, 2003
Clinical and biological effects of interleukin-2 with or without a concomitant administration of granulocyte-macrophage colony-stimulating factor in metastatic cancer patients
P Lissoni, S Mengo, R Bucovec, et al.
The International Journal of Biological Markers
|
February 24, 2001
Chemotherapy and angiogenesis in advanced cancer: vascular endothelial growth factor (VEGF) decline as predictor of disease control during taxol therapy in metastatic breast cancer
P Lissoni, E Fugamalli, F Malugani, et al.
Journal of Biological Regulators and Homeostatic Agents
|
April 7, 2004
A psychoncological study of lymphocyte subpopulations in relation to pleasure-related neurobiochemistry and sexual and spiritual profile to Rorschach's test in early or advanced cancer patients
G Messina, P Lissoni, E Bartolacelli, et al.
Journal of Biological Regulators and Homeostatic Agents
|
October 1, 1996
Reactivation of a normal endogenous secretion of interleukin-2 in metastatic cancer patients by a chronic subcutaneous injection of interleukin-2
G Di Felice, L Fumagalli, F Majorca, et al.
Cancer Treatment Reports
|
February 1, 1976
Combination chemotherapy with DTIC (NSC-45388) in advanced malignant melanoma, soft tissue sarcomas, and Hodgkin's disease
G Beretta, G Bonadonna, E Bajetta, et al.
Oncology
|
November 1, 1993
A study of the mechanisms involved in the immunostimulatory action of the pineal hormone in cancer patients
P Lissoni, S Barni, G Tancini, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1990
The biological significance of soluble interleukin-2 receptors in solid tumors
P Lissoni, S Barni, F Rovelli, et al.
Page
of 22